Philippe Lopes-Fernandes
Corporate Officer/Principal at IPSEN
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sree Kant | M | - |
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | 4 years |
| Omar F. Zouani | M | - |
Histide AG
 Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | 10 years |
| Veronika Gocheva | F | - |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | 10 years |
| Evripidis Gavathiotis | M | - |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | 4 years |
| Margaret Liu | M | 67 | 7 years | |
| Jennifer Miller | F | - |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | - |
| Benoît Lienard | M | - |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | 10 years |
| David Loew | M | 57 | 4 years | |
| Piet Wigerinck | M | 58 | 6 years | |
| Aymeric Le Chatelier | M | 55 | 10 years | |
| Yibing Shan | M | - |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | - |
| Marc M. P. de Garidel | M | 66 | 14 years | |
| Geeta S. Vemuri | M | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 7 years |
| Michèle Ollier | M | 66 | 9 years | |
| Karen Witts | F | 61 | 2 years | |
| Yuedan Claire Chen | M | - |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | - |
| Catherine Abi-Habib | F | - | 2 years | |
| Laetitia Ducroquet | F | 44 | 4 years | |
| Naomi Binoche | F | - | - | |
| Jerry Lipszyc | M | - |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | - |
| Renaud Caumartin | M | - |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | - |
| Alfredo E. Franco Mc Intosh | M | - |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | - |
| Christelle Huguet | M | 57 | 1 years | |
| Ioana Piscociu | F | - | - | |
| Marla McMillan | F | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Preston Noon | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| François-Maurice Garnier | M | 62 | 9 years | |
| Anna Mari Scheiffele | M | 50 | 3 years | |
| Antoine Flochel | M | 59 | 19 years | |
| Nicole Vitullo | F | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Norbert Riedel | M | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Bruce Peacock | M | 72 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Wayne H. Thompson | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Robert Hombach | M | 58 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Gwenan White | F | - | 3 years | |
| Henri Beaufour | M | 59 | 19 years | |
| Craig Marks | M | - | - | |
| Aidan Murphy | M | 58 | 6 years | |
| Carol Xueref | F | 67 | 12 years | |
| Regis Mulot | M | 58 | 6 years | |
| Royston Glasspool | M | 61 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 6 years |
| John Orloff | M | 66 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 3 years |
| Jak Knowles | M | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Robert Parkinson | M | 73 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | - |
| Jacopo Leonardi | M | 52 |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | 4 years |
| Sandra Silvestri | M | 50 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Sekhri | M | 66 | 5 years | |
| Carol Stuckley | F | 68 | 4 years | |
| Laurent Mousard | M | - |
Institut Supérieur de Gestion
| 4 years |
| Milenko Cicmil | M | - | 2 years | |
| Alexander McEwan | M | - | - | |
| Alexandre Lambert de Beaulieu | M | 52 |
Institut Supérieur de Gestion
| 4 years |
| Steven Hildemann | M | - | 3 years | |
| Mélanie d'Auzac de Lamartinie | F | 50 |
Institut Supérieur de Gestion
| 4 years |
| Pierre Boisselier | M | - |
Institut Supérieur de Gestion
| 3 years |
| Dominique Bery | F | 53 | 5 years | |
| Séverine Six | F | - |
Institut Supérieur de Gestion
| 4 years |
| Nathalie Wallace | F | - |
Institut Supérieur de Gestion
| 3 years |
| Ludovic Lastennet | M | - |
Institut Supérieur de Gestion
| 4 years |
| Eduardo Goya | M | - |
Institut Supérieur de Gestion
| 1 years |
| Howard Mayer | M | 61 | 4 years | |
| Richard Paulson | M | 56 | - | |
| Jérôme Rouquet | M | 56 |
Institut Supérieur de Gestion
| 4 years |
| Frédéric Michel-Verdier | M | 54 |
Institut Supérieur de Gestion
| 1 years |
| Guillaume Hemmerlé | M | 50 |
Institut Supérieur de Gestion
| 4 years |
| Bjarni K. Thorvardarson | M | - |
Institut Supérieur de Gestion
| 2 years |
| Chi Nguyen | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 43 | 64.18% |
| United States | 18 | 26.87% |
| Switzerland | 6 | 8.96% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Philippe Lopes-Fernandes
- Personal Network
